期刊文献+

破碎红细胞检测研究进展 被引量:2

Research Progress in the Detection of Schistocytes
下载PDF
导出
摘要 红细胞在血液循环中受到外在机械损伤而产生的破碎红细胞是诊断血栓性微血管病(thrombotic microangiopathy,TMA)的重要形态学线索。TMA代表性疾病有血栓性血小板减少性紫癜(Thrombocytopenic purpura,TTP)、溶血尿毒症综合征(hemolytic uremic syndrome,HUs)等,尤其是近年来,人们对移植相关血栓性微血管病的研究不断深入,外周血破碎红细胞检测越来越受到关注。但是关于破碎红细胞形态学诊断标准及破碎红细胞诊断TMA阈值等问题,由于工作人员个人经验、检测方法及疾病种类等差异,目前各实验室还没有一个完全统一的标准。并且随着近年来自动血细胞分析仪检测外周血破碎红细胞技术的发展,关于该技术检测方法的统一性、临床实用性及可靠性等问题也越来越受到人们的关注。该文将从手工检测方法及自动血细胞分析仪检测方法对目前临床上外周血破碎红细胞的检测进行总结。 Within the circulation, schistocytes are produced by extrinsic mechanical damage. Schistocyte is an important morphological clue to the diagnosis of thrombotic microangiopathy (TMA). The presence of schistocyte in the blood indicates the possibility of a thrombotic microangiopathy,in particular, the two major syndromes of thrombocytopenic purpura (TTP) and hemolytic uremic syndrome (HUS). In addition, with the increased study of hematopoietic stem cell transplantation as- sociated thrombotic microangiopathy, the detection of schistocytes has been paid more and more attention. Because of the differences of observers,methods and diseases, there are no full consensus criteria about the morphological of schistocytes and threshold value for the diagnosis of TMA. Recently, with the development of automated red blood cells (RBCs) fragment count, the reliability and clinical utility of automated schistocytes count has also been paid attention by more and more people. They will summary the detection of schistocytes from the two aspects of manual microscopy and automated RBCs fragment count.
出处 《现代检验医学杂志》 CAS 2016年第2期1-4,共4页 Journal of Modern Laboratory Medicine
基金 首都临床特色应用研究(Z141107006614003) 国家自然科学基金(81550041)
关键词 破碎红细胞 血栓性微血管病 光学显微镜 自动检测仪 regged red fiber thrombotic microangiopathy optical microscopy automated RBCs fragment count
  • 相关文献

参考文献18

  • 1Zini G,D'Onofrio G,Briggs C,et al.ICSH recommendations foridentification, diagnostic value,and quantitation of schistocytes[J].Int JLab Hematol,2012,34(2):107-116.
  • 2Moake JL.Thrombotic microangiopathies[J].N Engl J Med,2007,347(8):589-600.
  • 3Lesesve JF, Alla F, Dugue F,et al.Evaluation of schistocyte monitoring after haematopoietic stem cell transplantation[J].International Journal ofLaboratory Hematology,2011,33(4):343-356.
  • 4Ruutu T,Barosi G,Benjamin RJ,et al.Diagnostic criteria for hematopoietic stem cell transplant-associated microangiopathy:results of a consensus process by an International Working Group[J].Haematologica,2007,92(1):95-100.
  • 5Dacie JV,Lewis SM.Practical Hematology[M].4th Ed.London J&A Churchill,1968.
  • 6Glassy EF.Color atlas of hematology.An illustrated field guide based onproficiency testing[M].IL Northfield:College of American Pathologists,1998:1-370.
  • 7Yawn BP,Buchanan GR,Afenyi-annan AN,et al.Ma-nagement of sickle cell disease:summary of the 2014 evidence-based report by expert panel members[J].JAMA,2014,312(10):1033-1048.
  • 8Comite Nacional de Homatologia, Donato H, Crisp RL,et al.Hereditary spherocytosis:Review.part I.history,demographics,pathogenesis and diagnosis[J].Arch Argent Pediatr,2015,113(1):69-80.
  • 9Luzzatto L,Seneca E.G6PD deficiency:a classic example of pharmacogenetics with ongoing clinical implications[J].British Journal of Haematology,2014,164(4):469-480.
  • 10Lesesve JF,Salignac S,Lecompte T.Laboratory me-asurement ofschistocytes[J].International Journal of Laboratory Hematology,2007,29(2):149-151.

同被引文献11

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部